Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.45133 | 56 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.51959 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.45521 | 57 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.37091 | 56 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.37763 | 56 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.60941 | 59 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.49612 | 56 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.47054 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.41018 | 56 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.42722 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.42525 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.41195 | 57 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.43058 | 56 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.44189 | 57 |